|
| 28 Jun 2010 | Update on RPL554 and Cough Projects |
|
| 18 Jun 2010 | Grant of Options |
|
| 03 Jun 2010 | AGM Statement 3 June 2010 |
|
| 04 May 2010 | 2009 Annual Report and Notice of AGM |
|
| 26 Mar 2010 | Preliminary Unaudited Results for year ended 31 December 2009 |
|
| 20 Jan 2010 | Notice of Interest |
|
| 14 Jan 2010 | New Year Progress Report on Verona Pharma plc |
|
| 06 Jan 2010 | Application for admission of new Ordinary Shares |
|
| 24 Dec 2009 | Result of General Meeting |
|
| 11 Dec 2009 | Director's Shareholding |
|
| 08 Dec 2009 | Posting of Circular |
|
| 08 Dec 2009 | Form of Proxy Verona Pharma PLC -- General Meeting |
|
| 08 Dec 2009 | Issue of equity to raise approximately £3 million |
|
| 28 Oct 2009 | Notice of Interest |
|
| 11 Sep 2009 | Further re: Board Appointment |
|
| 11 Sep 2009 | Board Appointment |
|
| 11 Sep 2009 | A single dose of RPL554 is safe and effective in patients with asthma |
|
| 04 Sep 2009 | Interim Results For The Six Months To 30 June 2009 |
|
| 04 Sep 2009 | Interim Results For The Six Months To 30 June 2009 |
|
| 02 Sep 2009 | Change in Adviser |
|
| 29 May 2009 | Update to Total Voting Rights |
|
| 22 May 2009 | Result of AGM |
|
| 20 May 2009 | Clinical Trial Update |
|
| 11 May 2009 | Issue of Equity |
|
| 31 Mar 2009 | Notification of Shareholder's Interest |
|
| 25 Mar 2009 | 2008 Preliminary Unaudited Results |
|
| 28 Jan 2009 | Verona Pharma obtains regulatory approval to conduct a clinical trial of its new anti-asthma drug RPL554 |
|
| 09 Jan 2009 | Notification of Shareholder's Interest |
|
| 11 Nov 2008 | Notification of Shareholder's Interest |
|
| 23 Sep 2008 | Interim Report for the six months ended 30 June 2008 |
|
| 09 Sep 2008 | Verona Pharma signs to begin human clinical trials for potential anti-asthma drug |
|
| 31 Jul 2008 | Total Voting Rights |
|
| 07 Jul 2008 | Issue of Equity following Options Exercise |
|
| 18 Jun 2008 | Pharma's search for novel anti-inflammatory polysaccharides (NAIPs) advances under new agreement |
|
| 28 May 2008 | Issue of Equity following Options Exercise |
|
| 23 May 2008 | Result of AGM |
|
| 19 May 2008 | Planned anti-asthma and hay fever treatment passes crucial tests |
|
| 14 May 2008 | Issue of Equity following Options Exercise |
|
| 30 Apr 2008 | Issue of Equity following Options Exercise |
|
| 02 Apr 2008 | 2007 Financial Results and AGM date |
|
| 19 Mar 2008 | Change of Registered Office |
|
| 26 Feb 2008 | Clinical trial planning underway for RPL554 as experimental inhalation toxicity studies near completion |
|
| 31 Jan 2008 | Total Voting Rights |
|
| 17 Jan 2008 | Notification of Shareholder's Interest |
|
| 11 Jan 2008 | Notification of Shareholder's Interest |
|
| 08 Jan 2008 | Notification of Shareholder's Interest |
|
| 07 Jan 2008 | Result of General Meeting and Director's Shareholdings |
|
| 31 Dec 2007 | Total Voting Shares in Company |
|
| 17 Dec 2007 | Proposed Placing and Notice of General Meeting |
|
| 10 Dec 2007 | Issue of Equity |
|
| 13 Nov 2007 | AIM-quoted Verona Pharma Seeks Drug Treatment for Coughing |
|
| 06 Nov 2007 | AIM-Quoted Verona Pharma Progresses Anti-Asthma Drug Studies |
|
| 04 Oct 2007 | Verona Pharma Launches Important Regulatory Studies for its Planned New Anti-asthma Drug |
|
| 10 Sep 2007 | Interim Report for the Six Months Ended 30 June 2007 |
|
| 16 Aug 2007 | Holding(s) in Company |
|
| 01 Aug 2007 | Verona Pharma plc Notification of Website Address |
|
| 04 Jul 2007 | Verona Pharma plc Result of AGM |
|
| 02 Jul 2007 | Director Shareholding |
|
| 25 Jun 2007 | Director Shareholding |
|
| 29 May 2007 | Verona Pharma Annual Report (Year Ended 31 December 2006) |
|
| 29 May 2007 | Verona Pharma plc Commences Pre-Clinical Studies of its Lead Compound RPL554 |
|
| 09 May 2007 | Verona Pharma Appoints WH Ireland as Nominated Adviser and Broker |
|
| 26 Apr 2007 | Preliminary Results for year ended 31 December 2006 |
|
| 20 Mar 2007 | Material Transfer Agreement with HepMim Biosciences |
|
| 05 Feb 2007 | Change of Director Shareholding |
|
| 22 Jan 2007 | Verona Pharma Engages Onyx Scientific to Manufacture RPL554 for Preclinical (Toxicology) and Clinical Studies |
|
| 15 Dec 2006 | Total Voting Rights and Share Capital |
|
| 15 Dec 2006 | Update on NAIPs Programme |
|
| 27 Nov 2006 | Verona Pharma plc Advances RPL554 Drug Development Project for Treatment of Respiratory Diseases |
|
| 16 Nov 2006 | Verona Pharma signs Material Transfer Agreement with Glycomar for NAIPs programme |
|
| 09 Nov 2006 | Change of Director Shareholding |
|
| 09 Nov 2006 | Change of Notifiable Interest |
|
| 02 Oct 2006 | Change of Company Secretary and Registered Office |
|
| 29 Sep 2006 | Verona Pharma announces interim financial results for 6 month period to 30 June 2006 |
|
| 18 Sep 2006 | Acquisition of Rhinopharma Limited by Verona Pharma plc and first day of dealings of enlarged share capital |
